Summary
A novel nanoparticle delivery system has been developed by employing the oppositely charged polymers chitosan (CS) and dextran sulfate (DS), and a simple coacervation process. Under the conditions investigated, the weight ratio of the two polymers is identified as a determining factor controlling particle size, surface charge, entrapment efficiency and release characteristics of the nanoparticles produced. Particles of 223 nm mean diameter were produced under optimal conditions with a zeta potential of approximately −32.6 mV. A maximum of 75% anti-angiogenesis peptide entrapment efficiency was achieved with a CS:DS weight ratio of 0.59∶1. The same nanoparticle formulation also showed slow and sustained peptide release over a period of 6 days. In contrast, the formulation containing a lower ratio of CS:DS (0.5∶1) was found to have reduced entrapment efficiency and more rapid peptide release characteristics. The results of this study suggest that physicochemical and release characteristics of the CS-DS nanoparticles can be modulated by changing ratios of two ionic polymers. The novel CS-DS nanoparticles prepared by the coacervation process have potential as a carrier for small peptides.
This is a preview of subscription content, access via your institution.
References
- 1.
Paul, W. and Sharma, C.P., S.T.P. Pharma Sci., 10 (2000) 5.
- 2.
Janes, K.A., Calvo, P. and Alonso, M.J., Adv. Drug Deliv. Rev., 47 (2001) 83.
- 3.
Xu, Y. and Du, Y., Int. J. Pharm., 250 (2003) 215.
- 4.
Chew, J.L., Wolfowicz, C.B., Mao, H.-Q., Leong, K.W. and Chua, K.Y., Vaccine, 21 (2003) 2720.
- 5.
Mao, H.-Q., Roy, K., Troung-Le, V.L., Janes, K.A., Lin, K.Y., Wang, Y., August, J.T. and Leong, K.W., J. Cont. Rel., 70 (2001) 399.
- 6.
Takeuchi, H., Yamamoto, H., and Kawashima, Y., Adv. Drug Deliv. Rev., 47 (2001) 39.
- 7.
Chen, Y., McCulloch, R.K. and Gray, B. N., J. Cont. Rel., 31 (1994) 49.
- 8.
Janes, K.A., Fresneau, M.P., Marazuela, A., Fabra, A. and Alonso, M.J., J. Cont. Rel., 73 (2001) 255.
- 9.
Tiyaboonchai, W., Woiszwillo, J. and Middaugh, C.R., Eur. J. Pharm. Sci., 19 (2003) 191.
- 10.
Tiyaboonchai, W., Woiszwillo, J., Sims, R.C. and Middaugh, C.R., Int. J. Pharm., 255 (2003) 139.
- 11.
Tobio, M., Gref, R., Sanchez, A., Langer, R. and Alonso, M.J., Pharm. Res., 15 (1998) 270.
- 12.
Zhang, Q., Shen, Z. and Nagai, T., Int. J. Pharm., 218 (2001) 75.
- 13.
Guerrero, D.Q., Allemann, E., Fessi, H. and Doelker, E., Drug Dev. Ind. Pharm., 24 (1988) 1113.
- 14.
Bae, D.G., Gho, Y.S., Yoon, W.H. and Chae, C.B., J. Biol. Chem., 275 (2000) 13588.
- 15.
Calvo, P., Remunan-Lopez, C., Vila-Jato, J.L. and Alonso, M.J., Pharm. Res., 14 (1997) 1431.
- 16.
Bantan-Polak, T., Kassai, M. and Grant, K.B., Anal. Biochem., 297 (2001) 128.
- 17.
Calvo, P., Remunan-Lopez, C., Vila-Jato, J.L. and Alonso, M.J., J. Appl. Poly. Sci., 63 (1997) 125.
- 18.
Fernandez-Urrusuno, R., Calvo, P., Remunan-Lopez, C., Vila-Jato, J.L. and Alonso, M.J., Pharm. Res., 6 (1999) 1576.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, Y., Mohanraj, V.J. & Parkin, J.E. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Lett Pept Sci 10, 621–629 (2003). https://doi.org/10.1007/BF02442596
Received:
Accepted:
Issue Date:
Key words
- chitosan
- dextran sulphate
- nanoparticles
- peptide delivery
- sustained-release